BIAFW
bioAffinity Technologies Inc. WarrantNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
-1.05
52W High
$0.81
52W Low
$0.05
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
-257.30%
Forward P/E
—
PEG Ratio
—
About bioAffinity Technologies Inc. Warrant
bioAffinity Technologies, Inc., a biotechnology company, is engaged in the development of non-invasive diagnostic tests and specific treatments for cancer. The company is headquartered in San Antonio, Texas.
Fundamentals
| Revenue (TTM) | $5.90M |
| Gross Profit (TTM) | $2.04M |
| EBITDA | $-11.97M |
| Operating Margin | -220.80% |
| Return on Equity | -1860.00% |
| Return on Assets | -125.10% |
| Revenue/Share (TTM) | $1.55 |
| Book Value | $0.56 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 19.00% |
| Shares Outstanding | 0 |
| Float | $7.89M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
192.51%
HV 20-Day
150.04%
HV 30-Day
163.40%
HV 60-Day
133.91%
HV Rank
—
Volatility is currently expanding
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on BIAFW and any ticker you trade — then tracks every position and per-strategy win rate.
Data last updated: 8/18/2026